Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Queensland Health
Cipla
Accenture
Medtronic
Cerilliant
Federal Trade Commission
Deloitte
QuintilesIMS

Generated: October 20, 2017

DrugPatentWatch Database Preview

Akorn Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AKORN INC, and what generic and branded alternatives to AKORN INC drugs are available?

AKORN INC has thirty-three approved drugs.

There are three tentative approvals on AKORN INC drugs.

Summary for Applicant: Akorn Inc

US Patents:0
Tradenames:30
Ingredients:30
NDAs:33
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc
PHENYLEPHRINE HYDROCHLORIDE
phenylephrine hydrochloride
SOLUTION/DROPS;OPHTHALMIC207926-002Jan 15, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Akorn Inc
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION075494-002Jun 30, 2000APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
TOBRAMYCIN
tobramycin
SOLUTION;INHALATION201422-001May 28, 2014ANRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
HYDASE
hyaluronidase
INJECTABLE;INJECTION021716-001Oct 25, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-003Jun 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
INJECTABLE;INJECTION075086-001Apr 9, 1998APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065305-003Jan 11, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065305-002Jan 11, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-002Jun 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075431-001Nov 29, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKesson
Express Scripts
Healthtrust
AstraZeneca
US Army
Julphar
Covington
Cipla
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot